6QYT

Solution NMR of synthetic analogues of nisin and mutacin ring A and ring B - Mutacin I Ring A truncated analogue

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H COSY	5.5 mg/mL Mutacin I Ring A truncated analogue	DMSO	TFA salt	5.0	1 atm	298	Bruker AVANCE 600
2	2D 1H-1H NOESY	5.5 mg/mL Mutacin I Ring A truncated analogue	DMSO	TFA salt	5.0	1 atm	298	Bruker AVANCE 600
3	2D 1H-13C HSQC	5.5 mg/mL Mutacin I Ring A truncated analogue	DMSO	TFA salt	5.0	1 atm	298	Bruker AVANCE 600
4	2D 1H-13C HMBC	5.5 mg/mL Mutacin I Ring A truncated analogue	DMSO	TFA salt	5.0	1 atm	298	Bruker AVANCE 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
simulated annealing		Xplor-NIH

NMR Ensemble Information
Conformer Selection Criteria	lo
Conformers Calculated Total Number	100
Conformers Submitted Total Number	15
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	Xplor-NIH	2.45	Schwieters, Kuszewski, Tjandra and Clore
2	refinement	Xplor-NIH	2.45	Schwieters, Kuszewski, Tjandra and Clore
3	chemical shift assignment	CcpNmr Analysis		CCPN
4	peak picking	CcpNmr Analysis		CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.